Earnings History Data for Assembly Biosciences, Inc. (ASMB) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Assembly Biosciences, Inc.
Assembly Biosciences, Inc. is a biopharmaceutical company. It develops therapies for infectious diseases and other disorders of the gastrointestinal (GI) system. Assembly's product portfolio consists of two late stage assets: VEN 307 for relief from pain associated with anal fissures and VEN 308 for the treatment of fecal incontinence. The Company is also developing novel microbiome-based technology for targeted oral delivery of therapeutic bacteria, complex proteins, viral antigens and small molecules to treat intractable infectious diseases of the GI tract, such as C. difficile infections. Assembly Biosciences Inc., formerly known as Ventrus Biosciences, Inc., is based in New York.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08-11-2023 | AH | ASMB | Assembly Biosciences | 46.00 | -0.27 | -0.23 | 0.00 | Assembly Biosciences GAAP EPS of -$0.27 misses by $0.04 [11/8/2023 5:18 PM] |
0.7475 | -0.10 (-12.22%) |
0.86 | 0.01 (1.00%) |
0.67 - 1.78 | 1,767,461 | 710,000 | 7,946 | ||
| 22-03-2023 | AH | ASMB | Assembly Biosciences | 60.00 | -0.46 | -0.56 | 0.00 | Assembly Biosciences GAAP EPS of -$1.92 in-line [3/22/2023 4:58 PM] |
1.07 | -0.10 (-8.54%) |
1.18 | 0.01 (0.85%) |
0.82 - 2.42 | 578,500 | 210,000 | 2,109 | ||
| 08-11-2022 | AH | 4:05 PM ET (Nov 8) |
ASMB | Assembly Biosciences | 74.00 | -0.48 | -0.47 | 0.00 | Assembly Biosciences GAAP EPS of -$0.48 beats by $0.06 [11/8/2022 5:04 PM] |
1.30 | -0.07 (-5.11%) |
1.34 | -0.03 (-2.19%) |
1.20 - 3.15 | 414,227 | 230,000 | 6,908 | |
| 09-08-2022 | AH | 4:05 PM ET (Aug 9) |
ASMB | Assembly Biosciences | 104.00 | -0.51 | -0.49 | 0.00 | Assembly Biosciences GAAP EPS of -$0.51 [8/9/2022 5:22 PM] |
2.17 | 0.01 (0.46%) |
2.15 | -0.01 (-0.46%) |
1.32 - 3.94 | 284,251 | 300,000 | 500 | |
| 05-08-2021 | AH | 4:05 PM ET (Aug 5) |
ASMB | Assembly Biosciences, Inc. | 139.35 | -0.55 | -0.64 | 0.19 | Assembly Biosciences EPS beats by $0.11 [8/5/2021 5:07 PM] |
3.66 | 0.02 (0.41%) |
3.70 | 0.05 (1.37%) |
3.32 - 23.39 | 863,376 | 880,000 | 5,184 | |
| 06-05-2021 | AH | 4:05 PM ET (May 6) |
ASMB | Assembly Biosciences, Inc. | 162.64 | -0.69 | -0.79 | -0.76 | Assembly Biosciences EPS beats by $0.10 [5/6/2021 5:07 PM] |
4.05 | 0.13 (3.32%) |
3.96 | 0.04 (1.02%) |
3.84 - 27.84 | 584,179 | 930,000 | 3,432 | |
|
||||||||||||||||||
| 05-11-2020 | AH | ASMB | Assembly Biosciences, Inc. | 488.88 | -0.09 | -0.78 | -0.96 | Assembly Biosciences EPS beats by $0.69, beats on revenue [11/5/2020 4:58 PM] |
4.82 | -11.08 (-69.69%) |
6.25 | -9.65 (-60.69%) |
4.78 - 27.84 | 19,572,878 | 320,856 | 1,384,207 | ||
|
|
||||||||||||||||||